Higher levels of MIG and MIP-1α in our study have confirmed the evidence reported by several studies illustrating that MIG and MIP-1α recruit immune cells and contribute to the neuroinflammatory response to brain damage in various neurological disorders such as multiple sclerosis (Rydbirk et al., 2019). This evidence concerns the gene CCL3 and nervous system disorder.